Spineology received a US $5MM investment via convertible debenture from Hermed Capital, a private equity fund in Shanghai, China. Proceeds will fund commercialization, product development and clinical research.
Spineology received FDA 510(k) clearance for the Rampart One Anterior Lumbar Interbody Fusion system in 2Q17, and for Rampart Duo just over one year ago.
Rampart Duo combines PEEK, titanium and graft containment mesh elements, and is designed to reduce the surgical access required for lateral procedures while providing a large device footprint. Rampart One is also designed to minimize exposure and retraction requirements, and is made from Invibio® PEEK-OPTIMA® HA Enhanced material.
Other products from Spineology include the Elite Expandable interbody device, Palisade Pedicular Fixation and the ACT MediaLIF platform.
Spineology received a US $5MM investment via convertible debenture from Hermed Capital, a private equity fund in Shanghai, China. Proceeds will fund commercialization, product development and clinical research.
Spineology received FDA 510(k) clearance for the Rampart One Anterior Lumbar Interbody Fusion system in 2Q17, and for Rampart Duo just...
Spineology received a US $5MM investment via convertible debenture from Hermed Capital, a private equity fund in Shanghai, China. Proceeds will fund commercialization, product development and clinical research.
Spineology received FDA 510(k) clearance for the Rampart One Anterior Lumbar Interbody Fusion system in 2Q17, and for Rampart Duo just over one year ago.
Rampart Duo combines PEEK, titanium and graft containment mesh elements, and is designed to reduce the surgical access required for lateral procedures while providing a large device footprint. Rampart One is also designed to minimize exposure and retraction requirements, and is made from Invibio® PEEK-OPTIMA® HA Enhanced material.
Other products from Spineology include the Elite Expandable interbody device, Palisade Pedicular Fixation and the ACT MediaLIF platform.
Copy to clipboard 
